The trials give a lot of details about common side effects
At 24 weeks, participants receiving the highest dose achieved a mean body weight reduction of approximately 17.5%, representing some of the most substantial weight loss data observed in a Phase 2 obesity trial to date
Weeks 1-4: light activity like walking 20-30 minutes daily
But few people get that support especially those prescribed GLP-1s from their primary care physicians (PCPs)
Semaglutide was first designed as a treatment for diabetic patients, however, it also had weight loss properties
More recently, Choi and colleagues evaluated the cost-effectiveness of SGLT2is and GLP-1RAs, taken individually, as first-line therapies for American patients with T2DM, compared with metformin as first-line therapy